Drent, E., Groen, R., Noort, W., van Bueren, J. L., Parren, P., Kuball, J., . . . Mutis, T. (2015). Preclinical evaluation of CD38 chimeric antigen receptor engineered T cells for the treatment of multiple myeloma. J Immunother Cancer.
Παραπομπή Chicago StyleDrent, Esther, et al. "Preclinical Evaluation of CD38 Chimeric Antigen Receptor Engineered T Cells for the Treatment of Multiple Myeloma." J Immunother Cancer 2015.
Παραπομπή MLADrent, Esther, et al. "Preclinical Evaluation of CD38 Chimeric Antigen Receptor Engineered T Cells for the Treatment of Multiple Myeloma." J Immunother Cancer 2015.
Πρόσοχή: Οι παραπομπές μπορεί να μην είναι 100% ακριβείς.